FFM

Fairmount Funds Management Portfolio holdings

AUM $772M
1-Year Est. Return 35.05%
This Quarter Est. Return
1 Year Est. Return
+35.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$946M
AUM Growth
+$115M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$12.7M
2
+$11.1M
3
+$7.17M
4
AXSM icon
Axsome Therapeutics
AXSM
+$1.5M
5
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$1.49M

Top Sells

1
+$38.8M
2
+$33.7M
3
+$32M
4
IMVT icon
Immunovant
IMVT
+$28.8M
5
TRVI icon
Trevi Therapeutics
TRVI
+$11.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$188M 19.85%
2,360,077
+18,839
2
$176M 18.58%
5,929,592
3
$142M 14.96%
1,924,626
-527,193
4
$82.2M 8.68%
2,941,176
5
$77.5M 8.18%
1,245,929
+24,025
6
$50.6M 5.34%
2,883,221
+408,660
7
$43M 4.54%
112,903
+29,156
8
$29.8M 3.15%
1,369,623
9
$29.5M 3.12%
2,131,369
10
$27.3M 2.88%
3,554,129
+1,652,732
11
$20.9M 2.21%
3,558,975
12
$20.1M 2.12%
1,928,503
13
$19.7M 2.08%
717,254
-1,164,091
14
$19.3M 2.04%
1,393,329
15
$13.2M 1.4%
2,040,000
16
$8.14M 0.86%
378,421
17
– –
-678,115
18
– –
-750,000
19
– –
-1,142,473
20
– –
-5,163,287